Astrazeneca (AZN) Receivables (2009 - 2026)
Astrazeneca's Receivables came in at $15.68 billion for Q2 2026, up 2.9% from $15.23 billion a year earlier and up 2.5% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Astrazeneca's Receivables was $16.5 billion, up 18.7% from FY2024.
- Receivables has increased in each of the last nine years, with a five-year compound annual growth rate of 16.3% (FY2020 to FY2025).
- Going back by year, Receivables was $13.9 billion in FY2024 (+7.5%), $12.93 billion in FY2023 (+13.9%), $11.36 billion in FY2022 (+7.8%) and $10.54 billion in FY2021 (+36.1%).
- The five-year range for quarterly Receivables is $9.07 billion (Q3 2021) to $16.5 billion (Q4 2025).
- Year-over-year, Receivables has increased for 24 consecutive quarters, with growth averaging 14.1% over the last eight quarters.
- Over the past five years, the year-over-year growth in Receivables ranged from 0.1% (Q2 2024) to 42.8% (Q3 2021).
- Business Quant data shows AZN's Receivables at $15.29 billion (Q1 2026), $16.5 billion (Q4 2025) and $15.5 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 10.66 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.68 Bn |
| Mar 31, 2026 | 15.29 Bn |
| Dec 31, 2025 | 16.50 Bn |
| Sep 30, 2025 | 15.50 Bn |
| Jun 30, 2025 | 15.23 Bn |
| Mar 31, 2025 | 14.18 Bn |
| Dec 31, 2024 | 13.90 Bn |
| Sep 30, 2024 | 12.79 Bn |
| Jun 30, 2024 | 11.85 Bn |
| Mar 31, 2024 | 11.82 Bn |
| Dec 31, 2023 | 12.93 Bn |
| Sep 30, 2023 | 12.06 Bn |
| Jun 30, 2023 | 11.84 Bn |
| Mar 31, 2023 | 10.97 Bn |
| Dec 31, 2022 | 11.36 Bn |
| Sep 30, 2022 | 10.13 Bn |
| Jun 30, 2022 | 9.79 Bn |
| Mar 31, 2022 | 9.55 Bn |
| Dec 31, 2021 | 10.54 Bn |
| Sep 30, 2021 | 9.07 Bn |
API Access
Astrazeneca Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();